Effectiveness of Ultrasound Guided Adductor Canal Block on Chronic Pain in Knee Osteoarthritis
CompletedNCT02695654
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Adductor canal block has become popular as effective mean for pain relief following knee surgery.This block has not been checked in chronic pain patients.The purpose of this study is to assess the efficacy and safety of adductor canal block on chronic knee pain in patients with knee osteoarthritis.
Study details
- Official title
- Effectiveness of Ultrasound Guided Adductor Canal Blockade With Levobupivacaine and Clonidine on Chronic Pain in Knee Osteoarthritis
- Conditions
- Interventions
- Drug: Levobupivacaine
- Drug: Clonidine
- Sponsor
- Mensur Salihovic
- Organization
- University Medical Centre Ljubljana
- Start date
- 2015-11
- Primary completion
- 2016-08
- Sex
- All
- Age range
- from 45 Years
- Results posted
- No results posted in this snapshot
- Countries
- Slovenia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Outpatients Had pain in knee at least 6 months before the study Knee osteoarthritis chronic pain was diagnosed based on medical history, knee X- ray and orthopedic examination. A sufficient level of education to understand study procedures and be able to communicate with site personnel \- Exclusion Criteria: * Any cardiovascular, hepatic, or renal conditions that would compromise participation, in the opinion of the investigator * Severe neurologic conditions interfere with knee condition * Narcotic dependent (opioid intake more than 3 months and more than 30 mg of daily oral morphine equivalents) * Coexisting severe hematological disorder or with deranged coagulation parameters * Psychiatric illnesses * Allergy to any of the drugs used in the study * Infection or malignancy at the site of block * Any active systemic infection
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02695654